drugset / Trial / NCT00288249
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the study drug is effective and safe in the treatment of patients with metastatic breast cancer
Timeline
- Start
- 2005-12
- Primary completion
- 2008-03
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sagopilone | Small molecule | 12 mg/m2 | Intravenous |
| Subject | Sagopilone | Small molecule | 16 mg/m2 | Intravenous |
| Subject | Sagopilone | Small molecule | 22 mg/m2 | Intravenous |